Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Shares Issued (2021 - 2024)

Biote (BTMD) has 4 years of Shares Issued data on record, last reported at -$154000.0 in Q3 2025.

  • For Q3 2025, Shares Issued fell 123.23% year-over-year to -$154000.0; the TTM value through Sep 2025 reached -$196000.0, down 136.77%, while the annual FY2024 figure was $282000.0, 95.83% up from the prior year.
  • Shares Issued reached -$154000.0 in Q3 2025 per BTMD's latest filing, up from -$527000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $302.8 million in Q2 2021 and bottomed at -$302.8 million in Q3 2021.
  • Average Shares Issued over 4 years is $862200.0, with a median of $85000.0 recorded in 2024.
  • Peak YoY movement for Shares Issued: fell 22.86% in 2024, then crashed 123.23% in 2025.
  • A 4-year view of Shares Issued shows it stood at -$302.8 million in 2021, then skyrocketed by 99.91% to -$276000.0 in 2023, then plummeted by 90.94% to -$527000.0 in 2024, then surged by 70.78% to -$154000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$154000.0 in Q3 2025, -$527000.0 in Q4 2024, and $663000.0 in Q3 2024.